NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting

<p>GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) &#8212; NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today announced that three abstracts have been accepted for poster presentation at the upcoming Society [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/neximmune-announces-presentations-at-the-society-for-immunotherapy-of-cancers-38th-annual-meeting/">NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>